Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR ) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Steven Cutler Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Patrick Donnelly - Citigroup Inc., Research Division Jack Meehan - Nephron Research LLC Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Charles Rhyee - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division David Windley - Jefferies LLC, Research Division Kyle Crews - UBS Investment Bank, Research Division Luke Sergott - Barclays Bank PLC, Research Division Christine Rains - William Blair & Company L.L.C.
Icon PLC (ICLR) Surpasses Q3 Earnings and Revenue Estimates
Icon PLC (ICLR) came out with quarterly earnings of $3.31 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.35 per share a year ago.
ICON: Solid Fundamentals Trump Regulatory Headwinds
In H1 2025, ICON's net book-to-bill ratio dropped to its lowest value since at least 2016. However, this ratio could improve since macroeconomic uncertainty is vanishing. ICON has a repurchase program of $1,000 million underway, which could buy approximately 6.90% of the company's outstanding common shares. Despite the challenging times, ICON is a profitable firm, has low debt, and presents symptoms of undervaluation compared to other CRO companies.
ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR ) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Barry Balfe - Chief Operating Officer Kate Haven - Vice President of Investor Relations Nigel Clerkin - Chief Financial Officer Steven A. Cutler - CEO & Director Conference Call Participants Charles Rhyee - TD Cowen, Research Division David Howard Windley - Jefferies LLC, Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Eric White Coldwell - Robert W.
ICON: Lower Guidance Downside And Expanded Repurchase Plan
ICON may be relatively undervalued, trading at a ~10% discount to IQVIA and offering an attractive ~7% free cash flow yield that markets seem to be responding to now. The CRO sector faces near-term headwinds from a weak biotech funding environment related to high interest rates and associated increased clinical trial cancellations and delays. Q2 is indicating to markets that there will eventually be a return to growth after the CRO industry comes off the easy-money-fueled innovation environment.
Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates
Icon PLC (ICLR) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $3.75 per share a year ago.
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?
The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to repurchase $750 million of its outstanding common shares.
Here's Why You Should Retain ICLR Stock in Your Portfolio Now
Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.
ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript
ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive Officer Nigel Clerkin - Chief Financial Officer Barry Balfe - Chief Operating Officer Conference Call Participants Ahmed Muhammad - Leerink Partners Patrick Donnelly - Citi David Windley - Jefferies Justin Bowers - Deutsche Bank Jack Meehan - Nephron Research Jailendra Singh - Truist Securities Max Smock - William Blair Dan Leonard - UBS Michael Ryskin - Bank of America Luke Sergott - Barclays Matt Sykes - Goldman Sachs Eric Caldwell - Baird Charles Rhyee - TD Cowen Casey Woodring - JPMorgan Josh Waldman - Cleveland Research Operator Good day and thank you for standing by. Welcome to the ICON plc Q1 2025 Earnings Conference Call.
ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down
ICLR posts mixed results in the first quarter of 2025 due to ongoing clinical development and market volatility.
